FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083378 [Registered on: 25/03/2025] Trial Registered Prospectively
Last Modified On: 08/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Bharangi Nagar Churna with rice soaked water in heavy bleeding along with increased duration of menses in age group of 13 to 19 years. 
Scientific Title of Study   A RANDOMIZED OPEN CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY OF BHARANGI NAGAR CHURNA WITH TANDULODAK IN TARUNI ASRUGDAR W.S.R. TO PUBERTY MENORRHAGIA 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Snehal Laxman Dongare  
Designation  PG Student of Prasutitantra avum strirog  
Affiliation  Yashwant Ayurvedic College Postgraduate Training and Research Centre Kodoli District Kolhapur  
Address  Department of Prasutitantra avum strirog OPD no 8 and15 Yashwant Ayurvedic College Postgraduate Training and Research Centre Kodoli District Kolhapur

Kolhapur
MAHARASHTRA
416114
India 
Phone  8308079218  
Fax    
Email  dongaresnehal1998@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kavita Mule 
Designation  Guide and Associate professor  
Affiliation  Yashwant Ayurvedic College Postgraduate Training and Research Centre Kodoli District Kolhapur  
Address  Department of Prasutitantra avum strirog OPD no 8 and 15 Yashwant Ayurvedic College Postgraduate Training and Research Centre Kodoli District Kolhapur

Kolhapur
MAHARASHTRA
416114
India 
Phone  9423277612  
Fax    
Email  kvt126@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Snehal Laxman Dongare 
Designation  PG Student of Prasutitantra avum strirog  
Affiliation  Yashwant Ayurvedic College Postgraduate Training and Research Centre Kodoli District Kolhapur  
Address  Department of Prasutitantra avum strirog OPD no 8 and 15 Yashwant Ayurvedic College Postgraduate Training and Research Centre Kodoli District Kolhapur

Kolhapur
MAHARASHTRA
416114
India 
Phone  8308079218  
Fax    
Email  dongaresnehal1998@gmail.com  
 
Source of Monetary or Material Support  
Self 
 
Primary Sponsor  
Name  Dr Snehal Laxman Dongare  
Address  Department of Prasutitantra avum strirog OPD no 8 and 15 Yashwant Ayurvedic College Postgraduate Training and Research Centre Kodoli District Kolhapur  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Snehal Laxman Dongare  Yashwant Ayurvedic College Postgraduate Training and Research Centre Kodoli   OPD no 8 and 15 of Prasuti Tantra avum strirog department Yashwant Ayurvedic Medical College PGT and RC Kodoli, District Kolhapur
Kolhapur
MAHARASHTRA 
8308079218

dongaresnehal1998@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E00-E89||Endocrine, nutritional and metabolic diseases. Ayurveda Condition: ARTAVAVRUDDHIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Bharangi Nagar Churna , Reference: Bhavprakash Chikitsa,strirogadhikar adhyay 68/13,page no 755, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: Tandulodak ), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Nagkeshar Churna , Reference: Bhav Mishra,Bhav Prakash Nighantu,Karpuradi varg shlok 69 to 71 page no 78, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: Water), Additional Information: -
 
Inclusion Criteria  
Age From  13.00 Year(s)
Age To  19.00 Year(s)
Gender  Female 
Details  1 Age 13 to 19 years unmarried girls
2 Patients with complaints of excessive bleeding per vagina during
menstruation either in amount or duration
3 Polymenorrhagia
4 Patient with Hb 9gper dl or more than 9g per dl 
 
ExclusionCriteria 
Details  1Known case of Endocrinal Disorder like Hypo or Hyperthyroidism PCOS
2 Known case of Bleeding Dyscrasias
3 Known case of Structural Abnormality in Genital Organ
4Known case of systemic disorders 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of Bharangi Nagar churna with tandulodak in Taruni
Asrugdar W.S.R. to Puberty Menorrhagia. 
1st and 5th day of every cycle and after cessation of menses of every cycle for 3 consecutive cycles  
 
Secondary Outcome  
Outcome  TimePoints 
1. To reduce duration & amount of bleeding.
2. To assess improvement by parameters like PBAC.
3. To achieve the control on excessive bleeding.
4. To study the etio-pathology of asrugdar in detail according to Ayurvedic &
puberty menorrhagia details according to modern text.
5. To achieve the out-come of study in 90 days (3 Menstrual cycles). 
90 days 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [dongaresnehal1998@gmail.com].

  6. For how long will this data be available start date provided 18-03-2025 and end date provided 18-03-2030?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary   This is randomised open controlled clinical trial to study the efficacy of bharangi nagar churna with tandulodak in taruni asrugdar in pubertal age group conducted at OPD no 8 and 15 of Yashwant dharmarth rugnalaya kodoli kolhapur. The result will be assess after 90 days of study. 
Close